For research use only. Not for therapeutic Use.
JMS-053 is a potent, selective and reversible PTP4A inhibitor, with IC50s of 29.1 nM, 48.0 nM, 34.7 nM, 92.6 nM, and 207.6 nM for PTP4A1, PTP4A2, PTP4A3, CDC25B, and DUSP3, respectively. JMS-053 can inhibit cancer cell migration and spheroid growth in vitro, attenuate in vivo ovarian tumor growth[1].
| Catalog Number | I029802 |
| CAS Number | 1954650-11-3 |
| Synonyms | 7-imino-2-phenylthieno[3,2-c]pyridine-4,6-dione |
| Molecular Formula | C13H8N2O2S |
| Purity | ≥95% |
| InChI | InChI=1S/C13H8N2O2S/c14-10-11-8(12(16)15-13(10)17)6-9(18-11)7-4-2-1-3-5-7/h1-6,14H,(H,15,16,17) |
| InChIKey | CQHAROORCYWRRH-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C=C1)C2=CC3=C(S2)C(=N)C(=O)NC3=O |
| Reference | [1]. Lazo JS, et, al. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase. J Pharmacol Exp Ther. 2019 Dec;371(3):652-662. |
